Matthew Davis

10.4k total citations · 1 hit paper
45 papers, 3.3k citations indexed

About

Matthew Davis is a scholar working on Gender Studies, General Health Professions and Epidemiology. According to data from OpenAlex, Matthew Davis has authored 45 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gender Studies, 10 papers in General Health Professions and 8 papers in Epidemiology. Recurrent topics in Matthew Davis's work include Diversity and Career in Medicine (10 papers), Respiratory viral infections research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Matthew Davis is often cited by papers focused on Diversity and Career in Medicine (10 papers), Respiratory viral infections research (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Matthew Davis collaborates with scholars based in United States, Italy and Switzerland. Matthew Davis's co-authors include Juan Verdaguer, C. P. Wilkinson, Anselm Kampik, Paul P. Lee, R Pararajasegaram, Diana Dills, Frederick L. Ferris, Ronald Klein, Miguel Ángel Cano and Linda G. Castillo and has published in prestigious journals such as Cancer, The Journal of Infectious Diseases and Ophthalmology.

In The Last Decade

Matthew Davis

39 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

2003 2.7k citations C. P. Wilkinson, Frederick L. Ferris et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Davis United States	15	2.1k	1.9k	355	308	249	45	3.3k
Robert E. J. Ryder United Kingdom	30	674 0.3×	776 0.4×	311 0.9×	1.1k 3.5×	484 1.9×	167	3.2k
John H. Kempen United States	49	6.1k 2.8×	1.4k 0.7×	1.8k 5.0×	110 0.4×	512 2.1×	194	7.5k
Chris Andrews United States	35	745 0.3×	621 0.3×	358 1.0×	280 0.9×	827 3.3×	151	3.5k
Melissa M. Brown United States	36	2.7k 1.2×	1.8k 1.0×	1.2k 3.3×	175 0.6×	251 1.0×	156	4.3k
Euijung Ryu United States	34	382 0.2×	412 0.2×	347 1.0×	48 0.2×	447 1.8×	129	2.8k
Wanjiku Mathenge United Kingdom	25	1.4k 0.7×	1.1k 0.6×	741 2.1×	92 0.3×	93 0.4×	58	2.1k
Jennifer L. Patnaik United States	22	782 0.4×	630 0.3×	383 1.1×	33 0.1×	185 0.7×	133	2.3k
Augusto Azuara‐Blanco United Kingdom	39	4.5k 2.1×	4.4k 2.3×	651 1.8×	54 0.2×	284 1.1×	225	6.5k
John S. Wittenborn United States	24	591 0.3×	426 0.2×	874 2.5×	79 0.3×	118 0.5×	45	2.3k
Kristina Lindsley United States	27	2.0k 0.9×	1.5k 0.8×	552 1.6×	20 0.1×	462 1.9×	70	3.2k

Countries citing papers authored by Matthew Davis

Since Specialization

Citations

This map shows the geographic impact of Matthew Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Davis more than expected).

Fields of papers citing papers by Matthew Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Davis. The network helps show where Matthew Davis may publish in the future.

Co-authorship network of co-authors of Matthew Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Davis. A scholar is included among the top collaborators of Matthew Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Davis. Matthew Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuzhi, et al.. (2024). Assessment of the gender gap in urology industry payments: An Open Payments Program data analysis. Investigative and Clinical Urology. 65(4). 411–411. 1 indexed citations

Davis, Matthew, et al.. (2024). Chronic urticaria after Moderna COVID-19 vaccine boosters: A case series. JAAD Case Reports. 45. 27–30.

Davis, Matthew, Alex Stephens, Giuseppe Ottone Cirulli, et al.. (2024). Racial Disparities in Future Development of Lethal Prostate Cancer Based on Midlife Baseline Prostate‐Specific Antigen. The Prostate. 85(4). 354–363.

Davis, Matthew, Jeffrey Adelglass, Gordon Chau, et al.. (2023). Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults. Vaccine. 41(41). 5965–5973. 5 indexed citations

Arora, Sohrab, Anil K. Sood, Matthew Davis, et al.. (2023). Impact of preexisting opioid dependence on morbidity, length of stay, and inpatient cost of urological oncological surgery. World Journal of Urology. 41(4). 1025–1031. 1 indexed citations

Wassil, James, Jeff Fairman, Matthew Davis, et al.. (2023). Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial. The Lancet Infectious Diseases. 24(3). 308–318. 18 indexed citations

Cirulli, Giuseppe Ottone, Matthew Davis, Anil K. Sood, et al.. (2023). Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis. British Journal of Urology. 133(5). 555–563. 4 indexed citations

Abu‐Ghname, Amjed, et al.. (2020). The COVID-19 Pandemic: Implications for Medical Students and Plastic Surgery Residency Applicants. Plastic & Reconstructive Surgery. 146(3). 396e–397e. 5 indexed citations

Atmar, Robert L., Frank Baehner, Jakob P. Cramer, et al.. (2019). Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination. The Journal of Infectious Diseases. 220(4). 603–614. 22 indexed citations

10.

Davis, Matthew, et al.. (2015). Rhox8 Ablation in the Sertoli Cells Using a Tissue-Specific RNAi Approach Results in Impaired Male Fertility in Mice1. Biology of Reproduction. 93(1). 8–8. 23 indexed citations

11.

Heyward, William L., Matthew Davis, Keith S. Reisinger, et al.. (2013). Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age. Vaccine. 31(46). 5300–5305. 91 indexed citations

12.

Davis, Matthew, et al.. (2013). Regulated Expression of Rhox8 in the Mouse Ovary: Evidence for the Role of Progesterone and RHOX5 in Granulosa Cells1. Biology of Reproduction. 88(5). 126–126. 16 indexed citations

13.

Davis, Matthew, et al.. (2012). Uniting veterans across distance through a telephone-based reminiscence group therapy intervention.. Psychological Services. 9(2). 206–208. 4 indexed citations

14.

Davis, Matthew, Adnan Shahid Khan, & Walter Royal. (2012). Progressive Multifocal Leukoencephalopathy as the First Manifestation of Occult Sarcoidosis. The Neurologist. 19(1). 26–29. 13 indexed citations

15.

Ferguson, Murdo, George Risi, Matthew Davis, et al.. (2012). Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant. The Journal of Infectious Diseases. 205(5). 733–744. 47 indexed citations

16.

Schwartz, Seth J., Robert S. Weisskirch, Byron L. Zamboanga, et al.. (2010). Dimensions of acculturation: Associations with health risk behaviors among college students from immigrant families.. Journal of Counseling Psychology. 58(1). 27–41. 145 indexed citations

17.

Davis, Matthew. (2009). The Effects of Unemployment and Poverty on Sexual Appetite and Sexual Risk in Emerging and Young Adults. Sexual Addiction & Compulsivity The Journal of Treatment and Prevention. 16(4). 267–288. 8 indexed citations

18.

Cano, Miguel Ángel, et al.. (2009). Social problem-solving abilities, relationship satisfaction and depression among family caregivers of stroke survivors. Brain Injury. 23(2). 92–100. 25 indexed citations

19.

Wilkinson, C. P., Frederick L. Ferris, Ronald Klein, et al.. (2003). Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 110(9). 1677–1682. 2696 indexed citations breakdown →

20.

Doft, Bernard H., Sheryl F. Kelsey, Stephen R. Wisniewski, et al.. (1994). TREATMENT OF ENDOPHTHALMITIS AFTER CATARACT EXTRACTION. Retina. 14(4). 297–304. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact